Penserra Capital Management LLC increased its stake in HCP, Inc. (NYSE:HCP) by 25.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,030 shares of the real estate investment trust’s stock after buying an additional 606 shares during the quarter. Penserra Capital Management LLC’s holdings in HCP were worth $107,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Quest Capital Management Inc. ADV purchased a new position in HCP in the 3rd quarter worth approximately $28,000. Westside Investment Management Inc. acquired a new stake in HCP in the second quarter valued at approximately $31,000. NEXT Financial Group Inc raised its stake in shares of HCP by 181.3% during the second quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 725 shares during the period. Bartlett & Co. LLC purchased a new stake in shares of HCP during the third quarter valued at approximately $36,000. Finally, CSat Investment Advisory L.P. raised its stake in shares of HCP by 77.6% during the second quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 509 shares during the period. Institutional investors and hedge funds own 95.80% of the company’s stock.
In other HCP news, COO Thomas Klaritch sold 35,014 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares in the company, valued at approximately $8,303,654.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.13% of the company’s stock.
HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.52). The company had revenue of $538.00 million for the quarter, compared to analyst estimates of $503.65 million. HCP had a return on equity of 12.78% and a net margin of 43.66%. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 EPS. On average, equities analysts expect that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th were paid a dividend of $0.37 per share. The ex-dividend date was Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a yield of 4.24%. HCP’s dividend payout ratio (DPR) is 81.32%.
HCP has been the subject of several analyst reports. Stifel Nicolaus upped their target price on shares of HCP from $34.00 to $37.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. They noted that the move was a valuation call. ValuEngine downgraded shares of HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Morgan Stanley boosted their price objective on shares of HCP from $32.00 to $35.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 17th. Zacks Investment Research upgraded shares of HCP from a “hold” rating to a “buy” rating and set a $39.00 price objective on the stock in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $35.00 to $38.00 in a research report on Tuesday, October 8th. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $36.78.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Neutral Rating
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.